Germany's cannabis legalisation faces supply gaps and black market decline

Two years after Germany legalised cannabis for adults, the Green Party has raised concerns about a legal grey area in medical cannabis supplies. Janosch Dahmen, the party's health policy spokesperson, called the issue a 'gap in the system' and warned that current supply routes remain inadequate. The criticism follows the release of a second interim scientific report on cannabis legalisation. Findings show that the black market is shrinking without a notable rise in overall consumption. At the same time, the report highlights a drop in cannabis use among young people.

Dahmen emphasised that the Green Party's aim was to replace illegal sales with regulated access. However, he warned that new grey markets should not emerge in the process. Protecting young people's health, he stressed, must stay a priority under the current laws.

The report suggests progress in reducing illegal cannabis trade while keeping consumption stable. Yet, the Green Party insists that medical supply chains need urgent improvement. Lawmakers now face the task of closing the identified gaps without undermining existing safeguards.